In addition to DAG, increased FFAs supply can raise intracellular ceramides, which induce inflammation-associated insulin resistance by impairing insulin-mediated Akt activation in muscle (Chaurasia and Summers, 2015; Ritter et al., 2015). The gene discussed is AKT1; the disease is Insulin resistance.